Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Tomas Kalincik*, Vilija Jokubaitis, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Pierre Grammond, Alessandra Lugaresi, Celia Oreja-Guevara, Roberto Bergamaschi, Raymond Hupperts, Francois Grand'Maison, Eugenio Pucci, Vincent Van Pesch, Cavit Boz, Gerardo Iuliano, Ricardo Fernandez-Bolanos, Shlomo Flechter, Daniele Spitaleri, Edgardo Cristiano, Freek VerheulJeannette Lechner-Scott, Maria Pia Amato, Jose Antonio Cabrera-Gomez, Maria Laura Saladino, Mark Slee, Fraser Moore, Orla Gray, Mark Paine, Michael Barnett, Eva Havrdova, Dana Horakova, Timothy Spelman, Maria Trojano, Helmut Butzkueven

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1159-1171
JournalMultiple Sclerosis Journal
Volume21
Issue number9
DOIs
Publication statusPublished - Aug 2015

Keywords

  • Multiple sclerosis
  • treatment outcomes
  • patient registry
  • real-world date
  • propensity score
  • relapses
  • disability

Cite this